|
|
| Line 15: |
Line 15: |
|
| |
|
| ==Treatment== | | ==Treatment== |
| ===[[Upper respiratory tract infection medical therapy|Medical Therapy]]===
| |
| Judicious use of antibiotics can decrease unnecessary adverse effects of antibiotics as well as out-of-pocket costs to the patient. But more important, decreased antibiotic usage will prevent development of [[drug resistance|drug resistant bacteria]], which is now a growing problem in the world. International, as well as local US health agencies, have been strongly encouraging physicians to decrease the prescribing of antibiotics to treat common upper respiratory tract infections because antibiotic usage does not significantly reduce recovery time for these viral illnesses
| |
| [http://www.cochrane.org/reviews/en/ab004783.html]
| |
|
| |
| Some have advocated a delayed antibiotic approach to treating URIs which seeks to reduce the consumption of antibiotics while attempting to maintain patient satisfaction. Most studies show no difference in improvement of symptoms between those treated with antibiotics right away and those with delayed prescriptions.<ref>http://www.cochrane.org/reviews/en/ab004417.html Delayed antibiotics for symptoms and complications of respiratory infections</ref> Most studies also show no difference in patient satisfaction, patient complications, symptoms between delayed and no antibiotics. It should be noted that a strategy of "no antibiotics" results in even less antibiotic use than a strategy of "delayed antibiotics". Until more effective treatments are available to treat the common respiratory viruses responsible for the majority of cases, treatment of URIs with rest, increased fluids, and symptomatic care with over-the-counter medications will remain the treatment of choice. However, in certain higher risk patients with underlying lung disease, such as [[chronic obstructive pulmonary disease]] (COPD), evidence does exist to support the treatment of URIs with antibiotics to shorten the course of illness and decrease treatment failure.<ref>http://www.cochrane.org/reviews/en/ab004403.html Antibiotics for exacerbations of chronic obstructive pulmonary disease</ref>
| |
|
| |
| The use of [[Vitamin C]] in the prevention and treatment of upper respiratory infections has been suggested since the initial isolation of vitamin C in the 1930s. Several studies have failed to demonstrate that vitamin C supplementation reduces the incidence of colds in the normal healthy population, indicating that routine large dose prophylaxis with Vitamin C is not beneficial in widespread community usage. Some evidence exists to indicate that it could be justified in persons exposed to brief periods of severe physical exercise and/or cold environments. The evidence does not support the use of Vitamin C at the onset of colds as effective therapy.<ref>http://www.cochrane.org/reviews/en/ab000980.html Vitamin C for preventing and treating the common cold</ref>
| |
|
| |
| ==See also== | | ==See also== |
| * [[Lower respiratory tract infection]] | | * [[Lower respiratory tract infection]] |
For patient information click here
Template:DiseaseDisorder infobox
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Treatment
See also
References
Additional Resource
- Park, David J. "Evidence Based Approach to Upper Respiratory Infections." December 10, 2006. Touro University Nevada College of Osteopathic Medicine
External links
id:Infeksi saluran nafas atas
Template:WikiDoc Sources